VC Sift
Get started free

BioTech Investors in United States

588 investors · 429 with verified email

VCSift lists 588 BioTech investors in United States, 429 with a verified email address. They include 491 VC firms, 36 accelerators and 28 private equity investors. Profiles show firm, title, focus and, for subscribers, direct contact details.

BioTech United States
588 investors
EV

ExSight Ventures

New York, US VC Firm
Series A HealthTech BioTech
AC

Acorn Campus Ventures

Cupertino, US VC Firm
Series A BioTech
SC

ScaleReady

Saint Paul, US VC Firm
BioTech
NI

National Institute for Innovation in Manufacturing Biopharmaceuticals

Newark, US VC Firm
HealthTech BioTech
LP

Ligand Pharmaceuticals

San Diego, US VC Firm
Series A Series C HealthTech BioTech
AB

Abbott

Illinois City, US VC Firm
HealthTech BioTech
PA

Phenomenelle Angels

Madison, US Syndicate
Series A Seed BioTech
TC

Thynk Capital

Las Vegas, US VC Firm
Seed Series A HealthTech BioTech
PS

Palo Santo Fund

Highland Park, US Private Equity
Seed Series A HealthTech BioTech
SC

Supermoon Capital

San Francisco, US VC Firm
Series A Seed HealthTech BioTech SaaS +1 more
NV

Nest.Bio Ventures

Boston, US VC Firm
Series A Series C HealthTech BioTech
GH

Global Health Investment Fund (GHIF)

New York, US Private Equity
Growth Series C Fintech HealthTech BioTech
BV

Babel Ventures

San Francisco, US VC Firm
Series A Seed BioTech
NO

New Orleans BioFund

New Orleans, US Accelerator
Seed Growth BioTech
RV

Remeditex Ventures

Dallas, US VC Firm
Series A Series C HealthTech BioTech
AB

Ascent Biomedical Ventures

New York, US VC Firm
Series A Series C Fintech BioTech
BF

Baldrick's Foundation

Monrovia, US VC Firm
HealthTech BioTech EdTech
AC

Avoro Capital Advisors

New York, US Private Equity
Late Stage Growth Fintech BioTech
DC

Dynamk Capital

New York, US Accelerator
Series A Seed BioTech
TV

Tachyon Ventures

Los Angeles, US VC Firm
Series A Series C BioTech
OC

Otter Capital

Palo Alto, US Private Equity
Growth BioTech
WP

WPSS.bio

New York, US VC Firm
Series A Seed BioTech
AV

Arcus Ventures

New York, US Private Equity
Series A Series C Fintech BioTech
LO

LongeVC

Washington, US VC Firm
Series A Seed BioTech
OM

Oakwood Medical Investors

St Louis, US VC Firm
Series A Series C HealthTech BioTech
LC

L Capital Partners

New York, US VC Firm
Series A Series C Fintech BioTech
AC

Alpha Capital

Chicago, US Private Equity
Series A Series C Fintech BioTech SaaS
HB

H.I.G. BioHealth Partners

Miami, US VC Firm
Growth Series A BioTech
PE

Perseus

Washington, US Private Equity
Series A Series C BioTech Hardware
SV

Seaside Ventures

Austin, US VC Firm
Seed Series A BioTech InsurTech
PH

PureTech Health

Boston, US VC Firm
Fintech HealthTech BioTech
PV

Physic Ventures

San Francisco, US VC Firm
Series A Series C BioTech CleanTech
BC

Biomatics Capital Partners

Seattle, US VC Firm
Series A Series C HealthTech BioTech
BA

Billiken Angels Network

St Louis, US Accelerator
Series A Series C HealthTech BioTech SaaS
NC

Novaquest Capital Management

Raleigh, US Private Equity
Series A Series C Fintech BioTech
MD

Maryland Department of Business and Economic Development

Baltimore, US VC Firm
Series A Pre-Seed Fintech BioTech
HR

HealthCare Royalty Partners

Stamford, US Private Equity
Growth Fintech HealthTech BioTech
BV

Battelle Ventures

Trenton, US VC Firm
Series A Pre-Seed BioTech
EM

Emergent Medical Partners

Portola Valley, US VC Firm
Growth Series A Fintech HealthTech BioTech
NC

NGN Capital

New York, US VC Firm
Series A Series C BioTech
AT

Agilent Technologies

Santa Clara, US VC Firm
HealthTech BioTech
ES

Early Stage Partners

Cleveland, US Micro VC
Series A Series C Fintech BioTech
TH

Tullis Health Investors

Stamford, US Private Equity
Growth Series A HealthTech BioTech
NI

National Institute of General Medical Science

Bethesda, US Accelerator
HealthTech BioTech
RV

Reinforced Ventures

Pittsburgh, US VC Firm
Series A HealthTech BioTech SaaS
MV

Mid-Atlantic Venture Funds

Bethlehem, US VC Firm
Series A Series C Fintech BioTech
BC

Brookside Capital

San Francisco, US Private Equity
Series A Series C BioTech
MH

MP Healthcare Venture Management

Boston, US Corporate VC
Series A Seed BioTech
BI

Bioverge

San Francisco, US VC Firm
Series A Seed HealthTech BioTech
MV

MedImmune Ventures

Gaithersburg, US Corporate VC
Fintech BioTech

Other lists for United States

Fintech investors in United States (8,542) PropTech investors in United States (2,082) HealthTech investors in United States (1,779) SaaS investors in United States (1,589) EdTech investors in United States (735) MarTech investors in United States (641) Crypto/Web3 investors in United States (571) AI/ML investors in United States (439) Consumer investors in United States (396) InsurTech investors in United States (389) E-Commerce investors in United States (382) CleanTech investors in United States (324) Hardware investors in United States (163) Marketplace investors in United States (81) All investors in United States

BioTech investors by country and stage

BioTech investors in United Kingdom (71) BioTech investors in Canada (45) BioTech investors in Germany (42) BioTech investors in Switzerland (38) BioTech investors in France (28) BioTech investors in India (28) BioTech investors in Israel (24) BioTech investors in Spain (22) BioTech investors in Australia (22) Seed BioTech investors (2,840) Growth BioTech investors (1,900) Pre-Seed BioTech investors (519) Series A BioTech investors (292) Series C BioTech investors (108) All BioTech investors

Frequently asked questions about BioTech investors in United States

588 as of September 2026, 429 with a verified email address. They include 491 VC firms, 36 accelerators and 28 private equity investors.
Most investors on this list are individual angels rather than firm partners.
Yes. Essentials subscribers export up to 1,000 contacts a month as CSV; Pro subscribers have unlimited exports. Rows include name, firm, title, email, LinkedIn URL, stages, sectors and location.